Close

AbbVie (ABBV) Announces FDA Approval of RINVOQ

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. GM


Go back to AbbVie (ABBV) Announces FDA Approval of RINVOQ
AbbVie (NYSE: ABBV) Delayed: 167.80 -1.74 (1.03%)
Previous Close $169.54    52 Week High $68.12 
Open $168.52    52 Week Low $50.71 
Day High $169.11    P/E 36.40 
Day Low $166.74    EPS $4.61 
Volume 4,074,759